Biotage AB and Shanghai Chempartner Co., Ltd. sign multi-instrument deal
Chempartner's CEO, Michael Hui, says "We have expanded our operations over the last 4 years to accommodate the rapidly growing trend toward out-sourcing key elements of the drug discovery process. We need the most advanced tools available to create complex new molecules quickly and at high quality. Biotage provides a complete suite of automated tools that improve our workflow and allow our chemists to meet the high-standards of our clients; their instrument performance and proven reliability along with their strong commitment to our success were the key elements of our decision."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.